Literature DB >> 29102418

The utility of food antigen test in the diagnosis of Crohn's disease and remission maintenance after exclusive enteral nutrition.

Gefei Wang1, Jianan Ren2, Guanwei Li3, Qiongyuan Hu4, Guosheng Gu5, Huajian Ren6, Zhiwu Hong7, Jieshou Li8.   

Abstract

BACKGROUND: Crohn's disease (CD) involves intensive immunologic responses to food antigens. Exclusive enteral nutrition (EEN) showed efficacy in inducing disease remission. However, relapse commonly occurred when normal diet was reintroduced. We aimed to investigate the food-specific IgG antibodies of CD, and clarify the effects of exclusion diet guided by food-specific antibodies on remission maintenance after EEN.
METHODS: All available data of food-specific antibodies were retrieved from the database and analyzed for the diagnostic value. Thereafter, we retrospectively recruited qualified patients who reintroduced their diet excluding the moderately and strongly immunoreactive foods with prospective follow-up data. Matched patients without diet intervention after EEN served as control. CD activity index (CDAI), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and endoscopic score were compared.
RESULTS: A significantly enhanced immune response to rice, tomato, egg white/egg yolk and maize was observed in CD patients. The number of IgG-positive items had the greatest power to discriminate CD from ulcerative colitis and the control group with area under the curve of 0.819 and 0.828. Each diet group included 32 patients, and disease relapsed in 12.5% of the exclusion group compared with 25% of the control. The increase of CDAI and ESR was more remarkable in the control group than in the exclusion diet group (P<0.05).
CONCLUSIONS: CD patients presented intensive immune responses to food antigens. The number of IgG-positive food items had potential to be a diagnostic marker of CD. Diet guided by food antibody test might help maintain disease remission.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Crohn disease; Diagnosis; Diet therapy; Enteral nutrition

Mesh:

Substances:

Year:  2017        PMID: 29102418     DOI: 10.1016/j.clinre.2017.09.002

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  7 in total

Review 1.  Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?

Authors:  Konstantinos Gkikas; Konstantinos Gerasimidis; Simon Milling; Umer Z Ijaz; Richard Hansen; Richard K Russell
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

Review 2.  Review of Two Popular Eating Plans within the Multiple Sclerosis Community: Low Saturated Fat and Modified Paleolithic.

Authors:  Terry L Wahls; Catherine A Chenard; Linda G Snetselaar
Journal:  Nutrients       Date:  2019-02-07       Impact factor: 5.717

3.  Associations between food-specific IgG and health outcomes in an asymptomatic physical examination cohort.

Authors:  Mingxia Wu; Xiaofang Wang; Li Sun; Zongtao Chen
Journal:  Nutr Metab (Lond)       Date:  2022-03-19       Impact factor: 4.169

Review 4.  Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance.

Authors:  Camilla Fiorindi; Edda Russo; Lucrezia Balocchini; Amedeo Amedei; Francesco Giudici
Journal:  Nutrients       Date:  2022-10-03       Impact factor: 6.706

5.  Inflammatory Bowel Disease: Are Symptoms and Diet Linked?

Authors:  Hannah Morton; Kevin C Pedley; Robin J C Stewart; Jane Coad
Journal:  Nutrients       Date:  2020-09-29       Impact factor: 5.717

Review 6.  Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID).

Authors:  Marjo J E Campmans-Kuijpers; Gerard Dijkstra
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

Review 7.  Let Food Be Thy Medicine-Its Role in Crohn's Disease.

Authors:  Judith Wellens; Séverine Vermeire; João Sabino
Journal:  Nutrients       Date:  2021-03-03       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.